Your browser doesn't support javascript.
loading
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.
Flohr, T; Hess, G; Kolbe, K; Gamm, H; Nolte, H; Stanislawski, T; Huber, C; Derigs, H G.
Affiliation
  • Flohr T; IIIrd Department of Medicine, Johannes Gutenberg-University, Mainz, Germany.
Bone Marrow Transplant ; 29(9): 769-75, 2002 May.
Article in En | MEDLINE | ID: mdl-12040475
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Peripheral Blood Stem Cell Transplantation / Antibodies, Monoclonal / Neoplastic Cells, Circulating Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2002 Type: Article Affiliation country: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Peripheral Blood Stem Cell Transplantation / Antibodies, Monoclonal / Neoplastic Cells, Circulating Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2002 Type: Article Affiliation country: Germany